A new immunotherapy approach could work for many types of cancer
Using new molecules that block an immune checkpoint, researchers showed they could stimulate a strong anti-tumor immune response.
Using new molecules that block an immune checkpoint, researchers showed they could stimulate a strong anti-tumor immune response.
An AI-driven system lets users design and build simple, multicomponent objects by describing them with words.
Assistant Professor Yunha Hwang utilizes microbial genomes to examine the language of biology. Her appointment reflects MIT’s commitment to exploring the intersection of genetics research and AI.
Professors Ahmad Bahai and Kripa Varanasi, plus seven additional MIT alumni, are honored for highly impactful inventions.
Nuclear waste continues to be a bottleneck in the widespread use of nuclear energy, so doctoral student Dauren Sarsenbayev is developing models to address the problem.
MIT researchers found a way to predict how efficiently materials can transport protons in clean energy devices and other advanced technologies.
The approach could apply to more complex tissues and organs, helping researchers to identify early signs of disease.
Angela Koehler, Iain Cheeseman, and Katharina Ribbeck are shaping the collaborative as a platform for transformative research, translation, and talent development across MIT.
The “self-steering” DisCIPL system directs small models to work together on tasks with constraints, like itinerary planning and budgeting.
The new certificate program will equip naval officers with skills needed to solve the military’s hardest problems.
With its circular single-stranded DNA molecules, MIT spinout Kano Therapeutics plans to make gene and cell therapies safer and more effective.
Tools for forecasting and modeling technological improvements and the impacts of policy decisions can result in more effective and impactful decision-making.
The technique can help scientists in economics, public health, and other fields understand whether to trust the results of their experiments.
A study profiling antigens presented on immune and tumor cells in co-culture points to new strategies for attacking a treatment-resistant and deadly brain cancer.
Therapeutic antibodies packaged into microparticles could be injected with a standard syringe, avoiding the need for lengthy and often uncomfortable infusions.